Latest Insider Transactions at Biora Therapeutics, Inc. (BIOR)
This section provides a real-time view of insider transactions for Biora Therapeutics, Inc. (BIOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIORA THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIORA THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2021
|
Damon Silvestry Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,681
-1.25%
|
$11,043
$3.41 P/Share
|
|
Apr 15
2021
|
Damon Silvestry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,107
+19.9%
|
-
|
|
Mar 04
2021
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,608
-1.71%
|
$6,432
$4.05 P/Share
|
|
Mar 04
2021
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,609
-3.16%
|
$6,436
$4.05 P/Share
|
|
Mar 04
2021
|
George Gianakopoulos Senior Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
490
-2.2%
|
$1,960
$4.05 P/Share
|
|
Mar 04
2021
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
1,564
-2.99%
|
$6,256
$4.05 P/Share
|
|
Mar 04
2021
|
Sami Shihabi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-6.96%
|
$10,492
$4.05 P/Share
|
|
Feb 15
2021
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-1.28%
|
$3,310
$5.6 P/Share
|
|
Feb 15
2021
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,361
-5.39%
|
$26,805
$5.6 P/Share
|
|
Feb 15
2021
|
George Gianakopoulos Senior Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-1.66%
|
$1,885
$5.6 P/Share
|
|
Feb 15
2021
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-1.25%
|
$3,315
$5.6 P/Share
|
|
Feb 15
2021
|
Sami Shihabi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-2.41%
|
$4,660
$5.6 P/Share
|
|
Feb 15
2021
|
Harry Stylli Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,287
-0.08%
|
$56,435
$5.6 P/Share
|
|
Dec 19
2020
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-3.38%
|
$10,830
$6.32 P/Share
|
|
Dec 19
2020
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,228
-1.22%
|
$7,368
$6.32 P/Share
|
|
Dec 19
2020
|
Sami Shihabi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,757
-4.35%
|
$10,542
$6.32 P/Share
|
|
Dec 19
2020
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
1,726
-3.16%
|
$10,356
$6.32 P/Share
|
|
Dec 19
2020
|
Harry Stylli Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,615
-0.06%
|
$51,690
$6.32 P/Share
|
|
Dec 19
2020
|
George Gianakopoulos Senior Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
843
-3.59%
|
$5,058
$6.32 P/Share
|
|
Dec 16
2020
|
Damon Silvestry Officer |
BUY
Open market or private purchase
|
Direct |
58,081
+12.25%
|
$232,324
$4.55 P/Share
|
|
Dec 15
2020
|
Damon Silvestry Officer |
BUY
Open market or private purchase
|
Direct |
63,870
+28.13%
|
$255,480
$4.07 P/Share
|
|
Dec 14
2020
|
Jeffrey D. Alter |
BUY
Open market or private purchase
|
Direct |
20,000
+34.28%
|
$80,000
$4.85 P/Share
|
|
Dec 07
2020
|
Athyrium Opportunities Fund (A) LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,128,440
+13.27%
|
$12,385,320
$3.27 P/Share
|
|
Dec 07
2020
|
Athyrium Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,128,440
+13.27%
|
$12,385,320
$3.27 P/Share
|
|
Dec 02
2020
|
Harry Stylli Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
152,905
+1.04%
|
$458,715
$3.27 P/Share
|
|
Nov 15
2020
|
Damon Silvestry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+43.03%
|
-
|
|
Oct 15
2020
|
Troy Seelye Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,493
+28.28%
|
-
|
|
Jun 23
2020
|
Athyrium Capital Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
19,569,853
+24.55%
|
-
|
|
Jun 23
2020
|
Athyrium Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,333,333
+12.51%
|
$49,999,995
$15.0 P/Share
|